Table 1.
Baseline characteristics
| Clinical Characteristics | EHT Controls (n = 15) | PA Patients (n = 15) | P |
|---|---|---|---|
| Sex: male (%) | 7 (47) | 7 (47) | P = 1.00 |
| Age (years) | 47 (25-74) | 50 (35-71) | P = .55 |
| BMI (kg/m2) | 25.6 (3.5) | 25.8 (3.3) | P = .82 |
| Systolic BP (mm Hg) | 146 (14) | 155 (16) | P = .14 |
| Diastolic BP (mm Hg) | 83 (10) | 90 (11) | P = .08 |
| Fasting glucose, capillary | 5.2 (0. 6) | 5.2 (0.6) | P = .60 |
| Smoker; past (%) | 3 (20%) | 2 (13%) | P = .62 |
| Aldosterone (nmol/L) | 0.31 (0.07-0.51) | 0.97 (0.55-1.55) | P < 10–7 |
| Renin (nmol/L) | 20 (4-56) | 8 (< 3-23) | P = .08 |
| Total cholesterol (mmol/L) | 5.33 (0.94) | 5.11 (0.94) | P = .53 |
| HDL cholesterol (mmol/L) | 1.38 (0.39) | 1.34 (0.47) | P = .81 |
| LDL cholesterol (mmol/L) | 3.41 (0.81) | 3.04 (0.71) | P = .20 |
| Triglycerides (mmol/L) | 1.24 (0.76-2.27) | 1.58 (0.51-4.82) | P = .68 |
| Non-HDL cholesterol (mmol/L) | 3.97 (0.91) | 3.78 (0.86) | P = .56 |
Abbreviations: BMI, body mass index; BP, blood pressure; EHT, essential hypertension; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PA, primary aldosteronism.